SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Hippieslayer who wrote (23622)7/27/1998 11:46:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
I haven't heard the news, but that could have helped AGN finalize its rexinoid deal with WLA to treat diabetes (and of course LGND gets a royalty if these products come to market).



To: Hippieslayer who wrote (23622)7/27/1998 11:57:00 PM
From: Henry Niman  Respond to of 32384
 
Bloomberg is carrying the Rezulin label change tonight:
paradise-web.com



To: Hippieslayer who wrote (23622)7/28/1998 12:09:00 AM
From: Henry Niman  Respond to of 32384
 
Dow Jones is carrying the story and citing 21 deaths:
paradise-web.com


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News